NEW LEAF VENTURE PARTNERS

other names
{{ Info.Overview }}
Revenue {{ Info.Revenue | formatUSD }}
Headquarters {{ Info.Headquarters }}
cb

Adviser Profile
As of Date 03/28/2024
Adviser Type - Large advisory firm
Number of Employees 5
of those in investment advisory functions 3
Registration SEC, Approved, 1/15/2015
Other registrations (1)
AUM* 580,046,171 -4.20%
of that, discretionary 580,046,171 -4.20%
Private Fund GAV* 654,343,441 8.07%
Avg Account Size 64,449,575 -14.84%
SMA’s No
Private Funds 9 1
Contact Info 646 xxxxxxx
Websites

Client Types

- Pooled investment vehicles

Advisory Activities

- Portfolio management for pooled investment vehicles

Compensation Arrangments

- A percentage of assets under your management
- Performance-based fees

Recent News

Reported AUM

Discretionary
Non-discretionary
1B 924M 770M 616M 462M 308M 154M
2016 2017 2018 2019 2020 2021 2022 2023

Private Funds



Employees

Private Funds Structure

Fund Type Count GAV
Fund TypeVenture Capital Fund Count9 GAV$654,343,441

Similar advisers

Adviser Hedge Fund Liquidity Fund Private Equity Fund Real Estate Fund Securitized Asset Fund Venture Capital Fund Other Fund Total Private Fund GAV AUM #Funds
Adviser VARIANT Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund838.2m Other Fund- Total Private Fund GAV1.7b AUM838.2m #Funds7
Adviser BOW CAPITAL MANAGEMENT, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund- Other Fund- Total Private Fund GAV- AUM591.4m #Funds-
Adviser DARWIN VENTURES, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund593.4m Other Fund- Total Private Fund GAV1.2b AUM593.4m #Funds10
Adviser ELSEWHERE PARTNERS, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund778.8m Other Fund- Total Private Fund GAV1.6b AUM778.8m #Funds12
Adviser ANTHEMIS CAPITAL MANAGERS LIMITED Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund487.4m Other Fund- Total Private Fund GAV974.9m AUM608.9m #Funds4
Adviser AWM CAPITAL, LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund33.4m Other Fund- Total Private Fund GAV66.8m AUM860.6m #Funds6
Adviser RIVERPARK CAPITAL MANAGEMENT LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund210.0m Other Fund- Total Private Fund GAV420.0m AUM337.0m #Funds3
Adviser FINTECH COLLECTIVE MANAGEMENT LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund856.6m Other Fund- Total Private Fund GAV1.7b AUM861.1m #Funds13
Adviser UNION GROVE VENTURE PARTNERS Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund499.4m Other Fund- Total Private Fund GAV998.8m AUM621.7m #Funds8
Adviser VOLT INVESTMENT HOLDINGS LLC Hedge Fund- Liquidity Fund- Private Equity Fund- Real Estate Fund- Securitized Asset Fund- Venture Capital Fund1.1b Other Fund- Total Private Fund GAV2.2b AUM1.0b #Funds27

Top Holdings

Stock Ticker Stock Name $ Position % Position $ Change # Change
Stck Ticker28036F105 Stock NameEDGEWISE THERAPEUTICS INC $ Position$41,467,212 % Position43.00% $ Change48.00% # Change0.00%
Stck Ticker04335A105 Stock NameARVINAS INC $ Position$35,337,178 % Position36.00% $ Change3.00% # Change11.00%
Stck Ticker22663K107 Stock NameCRINETICS PHARMACEUTICALS INC $ Position$7,205,100 % Position7.00% $ Change14.00% # Change0.00%
Stck Ticker75120L100 Stock NameRALLYBIO CORPORATION $ Position$3,862,876 % Position4.00% $ Change-13.00% # Change0.00%
Stck Ticker77313F106 Stock NameROCKET PHARMACEUTICALS INC $ Position$2,783,540 % Position3.00% $ Change-14.00% # Change0.00%
Stck Ticker19240Q201 Stock NameCOGENT BIOSCIENCES INC. $ Position$2,708,262 % Position3.00% $ Change28.00% # Change0.00%
Stck Ticker014442107 Stock NameALECTOR INC $ Position$1,582,392 % Position2.00% $ Change3.00% # Change0.00%
Stck Ticker702712100 Stock NamePASSAGE BIO $ Position$1,748,545 % Position2.00% $ Change-12.00% # Change0.00%
Stck TickerG6333L200 Stock NameITERUM THERAPEUTICS PLC $ Position$376,072 % Position0.00% $ Change238.00% # Change255.00%
Stck Ticker98420X103 Stock NameX4 PHARMACEUTICALS INC $ Position$224,115 % Position0.00% $ Change15.00% # Change0.00%

Brochure Summary

Overview

New Leaf is a venture capital firm that was founded in 2005 and provides investment advisory services to various investment funds sponsored or organized by New Leaf (the “Funds”). The principal owners of New Leaf are Ron Hunt and Vijay Lathi. A related person of New Leaf generally acts as the general partner of (or in another equivalent management position for) each Fund. References to New Leaf in this Brochure include, as the context requires, affiliates through which New Leaf provides investment advisory services or that act in any capacity referenced in the previous sentence. References to “person” in this Brochure include, as the context permits, natural persons and entities. New Leaf focuses primarily on equity investments in venture and growth-stage healthcare and life sciences companies. Fund investments typically take the form of venture capital or growth capital transactions in private companies, or as structured transactions in small capitalization public companies. Although the primary focus of each Fund is on venture capital and growth equity investments in companies based in the U.S., New Leaf may from time to time recommend other types of investments (such as publicly traded equity, selective early-stage investments in privately-held companies or investments in companies outside of the U.S.) to the extent consistent with the respective Fund’s investment strategy and objectives and its Governing Documents (as defined below). New Leaf’s advisory services consist of: (i) investigating, identifying and evaluating investment opportunities; (ii) structuring, negotiating and making investments on behalf of the
Funds; (iii) managing and monitoring the performance of such investments; and (iv) exiting such investments on behalf of the Funds. New Leaf’s advisory services to each Fund are subject to the specific investment objectives and restrictions applicable to such Fund, as set forth in each Fund’s limited partnership agreement, confidential private placement memorandum and other governing documents (collectively, the “Governing Documents”). Investors and prospective investors in each Fund should refer to the Governing Documents of that Fund for information on the investment objectives and investment restrictions with respect to that Fund. There can be no assurance that any of the Funds’ investment objectives will be achieved. In accordance with common industry practice, one or more of the Funds or their general partners may enter into “side letters” or similar agreements with certain investors pursuant to which the Fund or its general partner grants the investor specific rights, benefits, or privileges that are not made available to investors generally. Such “side letters” or similar agreements generally are disclosed only to investors in the applicable Fund that have separately negotiated with New Leaf for the right to review such “side letters” or similar agreements. New Leaf does not participate in any wrap fee programs. New Leaf manages assets of the Funds on a discretionary basis in accordance with the terms and conditions of each Fund’s Governing Documents. New Leaf does not manage client assets on a non-discretionary basis. As of December 31, 2022, New Leaf’s regulatory assets under management were $605,472,129.